Oncocyte to Release First Quarter 2025 Results on May 12, 2025
IRVINE, Calif., May 7, 2025 – PRISM MediaWire – Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that it will report first
IRVINE, Calif., May 7, 2025 – PRISM MediaWire – Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that it will report first

Press Audio Overview: FORT LAUDERDALE, Fla., May 05, 2025 – PRISM MediaWire – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer

Press Audio: BROOMFIELD, Colo., May 05, 2025 – PRISM MediaWire – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that

Listened: Thomas Wolff · SS Innovations Announces Chief Financial Officer Transition Fort Lauderdale, FL, May 2, 2025 – PRISM MediaWire – SS Innovations International, Inc.

Expands access to first customer using Philips MR Spectroscopy (MRS), demonstrating ease of Nociscan integration across multiple MRS platforms Nociscan now commercially available at 17

Also Announces Company’s Record Backlog Of $19.8 Million, All Deliverable In FY2025! Listen: Hauppauge, NY, April 28, 2025 – PRISM MediaWire – AmpliTech Group, Inc.

Listened: Fort Lauderdale, FL, April 24, 2025 – PRISM MediaWire – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of

Broomfield, CO, April 23, 2025 – PRISM MediaWire – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers

The presentation will be webcast at 10:30 AM ET on April 22, 2025 POMPANO BEACH, Fla., April 21, 2025 – PRISM MediaWire – BioStem Technologies, Inc. (OTC:

Listen: BROOMFIELD, Colo., April 21, 2025 – PRISM MediaWire – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers
PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850